A systematic evaluation of respiratory disorders during sleep in sickle cell children: treatment with Hydroxycarbamide in the identification of isolated hypoxemia - double-blind, randomized, placebo-controlled clinical trial

Trial Profile

A systematic evaluation of respiratory disorders during sleep in sickle cell children: treatment with Hydroxycarbamide in the identification of isolated hypoxemia - double-blind, randomized, placebo-controlled clinical trial

Planning
Phase of Trial: Phase II

Latest Information Update: 09 Oct 2017

At a glance

  • Drugs Hydroxycarbamide (Primary)
  • Indications Sickle cell anaemia
  • Focus Therapeutic Use
  • Acronyms SOMMEDREP
  • Most Recent Events

    • 09 Oct 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top